Salvage Re-Irradiation for Recurrent Head and Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 731-740

  Lee, Nancy ^a   Chan, Kelvin ^a   Bekelman, Justin E ^a   Zhung, Joanne ^a   Mechalakos, James ^a   Narayana, Ashwatha ^a   Wolden, Suzanne ^a   Venkatraman, Ennapadam S ^a   Pfister, David ^a   Kraus, Dennis ^a   Shah, Jatin ^a   Zelefsky, Michael J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Head and neck; IMRT; Re irradiation; Recurrent

Indexed keywords

CHEMOTHERAPY; DISEASES; DOSIMETRY; RADIOTHERAPY;

INTENSITY MODULATED RADIATION THERAPY (IMRT); LOCO REGIONAL PROGRESSION-FREE SURVIVAL (LRPFS); REIRRADIATION;

ONCOLOGY;

CAPECITABINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIVARIATE ANALYSIS; NASOPHARYNX CANCER; NECK CANCER; OROPHARYNX CANCER; OVERALL SURVIVAL; PARANASAL SINUS CANCER; PAROTID GLAND CANCER; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT CANCER; RETREATMENT; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEW YORK; PREVALENCE; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; SALVAGE THERAPY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34249340144     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.055     Document Type: Article

References (39)

1. Brockstein B., Haraf D.J., Rademaker A.W., et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience. Ann Oncol 15 (2004) 1179-1186
2. Wong S.J., Machtay M., and Li Y. Locally recurrent, previously irradiated head and neck cancer: Concurrent re-irradiation and chemotherapy, or chemotherapy alone?. J Clin Oncol 24 (2006) 2653-2658
3. Wong L.Y., Wei W.I., Lam L.K., et al. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 25 (2003) 953-959
4. McLaughlin M.P., Parsons J.T., Fein D.A., et al. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx. Head Neck 18 (1996) 229-235
5. Agra I.M., Carvalho A.L., Ulbrich F.S., et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 28 (2006) 107-113
6. Agra I.M., Carvalho A.L., Pontes E., et al. Postoperative complications after en bloc salvage surgery for head and neck cancer. Arch Otolaryngol Head Neck Surg 129 (2003) 1317-1321
7. Parsons J.T., Mendenhall W.M., Stringer S.P., et al. Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys 32 (1995) 605-609
8. Creak A.L., Harrington K., and Nutting C. Treatment of recurrent head and neck cancer: Re-irradiation or chemotherapy?. Clin Oncol (R Coll Radiol) 17 (2005) 138-147
9. Stewart F.A. Re-treatment after full-course radiotherapy: Is it a viable option?. Acta Oncol 38 (1999) 855-862
10. Kasperts N., Slotman B., Leemans C.R., et al. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol 41 (2005) 225-243
11. Forastiere A.A., Metch B., Schuller D.E., et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10 (1992) 1245-1251
12. Forastiere A.A., Shank D., Neuberg D., et al. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial (PA390). Cancer 82 (1998) 2270-2274
13. Forastiere A.A., Leong T., Rowinsky E., et al. Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393. J Clin Oncol 19 (2001) 1088-1095
14. Gibson M.K., Li Y., Murphy B., et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 23 (2005) 3562-3567
15. Haraf D.J., Weichselbaum R.R., and Vokes E.E. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease. Ann Oncol 7 (1996) 913-918
16. De Crevoisier R., Bourhis J., and Eschwege F. Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) and re-irradiation in recurrent head and neck carcinomas. Cancer Treat Res 114 (2003) 199-212
17. Salama J.K., Vokes E.E., Chmura S.J., et al. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 64 (2006) 382-391
18. Dawson L.A., Myers L.L., Bradford C.R., et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 377-385
19. Puthawala A.A., and Syed A.M. Interstitial re-irradiation for recurrent and/or persistent head and neck cancers. Int J Radiat Oncol Biol Phys 13 (1987) 1113-1114
20. Syed A.M., Puthawala A.A., Damore S.J., et al. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial. Int J Radiat Oncol Biol Phys 47 (2000) 1311-1321
21. Tan E.H., Adelstein D.J., Saxton J.P., et al. Concurrent chemoradiotherapy for salvage in relapsed squamous cell head and neck cancer. Cancer Invest 15 (1997) 422-428
22. Chua D.T., Sham J.S., Hung K.N., et al. Salvage treatment for persistent and recurrent T1-2 nasopharyngeal carcinoma by stereotactic radiosurgery. Head Neck 23 (2001) 791-798
23. Chua D.T., Sham J.S., Leung L.H., et al. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol 77 (2005) 290-294
24. Chen Y.J., Kuo J.V., Ramsinghani N.S., et al. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer. Med Dosim 27 (2002) 171-176
25. Xia P., and Verhey L.J. Delivery systems of intensity-modulated radiotherapy using conventional multileaf collimators. Med Dosim 26 (2001) 169-177
26. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
27. Chui C.S., and Spirou S.V. Inverse planning algorithms for external beam radiation therapy. Med Dosim 26 (2001) 189-197
28. Services U.S. Department of Health. Common terminology criteria for adverse events (CTCAE): version 3.0. National Institutes of Health National Cancer Institute, editor (2003)
29. Wang C.C., and McIntyre J. Re-irradiation of laryngeal carcinoma-Techniques and results. Int J Radiat Oncol Biol Phys 26 (1993) 783-785
30. Kramer N.M., Horwitz E.M., Cheng J., et al. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies. Head Neck 27 (2005) 406-414
31. Spencer S.A., Harris J., Wheeler R.H., et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51 (2001) 1299-1304
32. Horowitz E.M., Harris J., Langer C.J., et al. Concurrent split course hyperfractionated radiotherapy, cisplatin, and paclitaxel in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck: Update of RTOG 9911. J Clin Oncol 23 (2005) 519s
33. De Crevoisier R., Domenge C., Wibault P., et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer 91 (2001) 2071-2076
34. De Crevoisier R., Bourhis J., Domenge C., et al. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16 (1998) 3556-3562
35. Machtay M., Rosenthal D.I., Chalian A.A., et al. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 59 (2004) 72-77
36. Janot F., De Raucourt D., Castaing M., et al. Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from the GETTEC and GORTEC groups. J Clin Oncol 24 (2006) 18s
37. Spencer S.A., Wheeler R.H., Peters G.E., et al. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Am J Clin Oncol 22 (1999) 1-5
38. Wang C.C. Re-irradiation of recurrent nasopharyngeal carcinoma-Treatment techniques and results. Int J Radiat Oncol Biol Phys 13 (1987) 953-956
39. Hwang J.M., Fu K.K., and Phillips T.L. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 41 (1998) 1099-1111